Condition
Cystic Fibrosis Modifier 1
Total Trials
1
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
Related Conditions
Often studied with 12 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Active Not Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Active Sponsors
- Herlev and Gentofte Hospital1
- Copenhagen University Hospital, Denmark1
Top Investigators
CF Centre Copenhagen University Hospital Rigshospitalet
Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital Rigshospitalet, University of Copenhagen
CF Centre Copenhagen University Hospital Rigshospitalet
Department of Cardiology, Department of Biomedical Sciences, Herlev and Gentofte University Hospital, University of Copenhagen
CF Centre Copenhagen University Hospital Rigshospitalet
Related Conditions
- Cystic Fibrosisrelated Diabetes1
- Cystic Fibrosis Gastrointestinal Disease1
- Left Ventricular Dysfunction1
- Stroke1
- Heart Failure Systolic1